(S)-2-amino-3-(1H-indol-3-yl)-N-(3-(7-methoxy-1,2,3,4-tetrahydroacridin-9-ylamino)propyl)propanamide dihydrochloride

ID: ALA4556372

Chembl Id: CHEMBL4556372

PubChem CID: 155556733

Max Phase: Preclinical

Molecular Formula: C28H35Cl2N5O2

Molecular Weight: 471.61

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1ccc2nc3c(c(NCCCNC(=O)[C@@H](N)Cc4c[nH]c5ccccc45)c2c1)CCCC3.Cl.Cl

Standard InChI:  InChI=1S/C28H33N5O2.2ClH/c1-35-19-11-12-26-22(16-19)27(21-8-3-5-10-25(21)33-26)30-13-6-14-31-28(34)23(29)15-18-17-32-24-9-4-2-7-20(18)24;;/h2,4,7,9,11-12,16-17,23,32H,3,5-6,8,10,13-15,29H2,1H3,(H,30,33)(H,31,34);2*1H/t23-;;/m0../s1

Standard InChI Key:  WXZWIKAVMLFELK-IFUPQEAVSA-N

Associated Targets(Human)

ACHE Tclin Acetylcholinesterase (18204 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Tclin Butyrylcholinesterase (7174 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCHE Tclin Cholinesterases; ACHE & BCHE (1222 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
APP Tclin Amyloid-beta A4 protein (8510 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

CHO-K1 (1115 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Nos3 Nitric oxide synthase, endothelial (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 471.61Molecular Weight (Monoisotopic): 471.2634AlogP: 4.09#Rotatable Bonds: 9
Polar Surface Area: 105.06Molecular Species: BASEHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 5#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 8.97CX LogP: 3.25CX LogD: 1.24
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.28Np Likeness Score: -0.52

References

1. Chalupova K, Korabecny J, Bartolini M, Monti B, Lamba D, Caliandro R, Pesaresi A, Brazzolotto X, Gastellier AJ, Nachon F, Pejchal J, Jarosova M, Hepnarova V, Jun D, Hrabinova M, Dolezal R, Zdarova Karasova J, Mzik M, Kristofikova Z, Misik J, Muckova L, Jost P, Soukup O, Benkova M, Setnicka V, Habartova L, Chvojkova M, Kleteckova L, Vales K, Mezeiova E, Uliassi E, Valis M, Nepovimova E, Bolognesi ML, Kuca K..  (2019)  Novel tacrine-tryptophan hybrids: Multi-target directed ligands as potential treatment for Alzheimer's disease.,  168  [PMID:30851693] [10.1016/j.ejmech.2019.02.021]

Source